Mathew Thomas
Health & Research Centre
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mathew Thomas as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:28 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT00814372 · Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on MetforminGilead Sciences · terminated · Type 2 Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:28 UTC. The ranking covers the 200 most relevant of 595 PubMed records, and a shared surname and initials can bring in a namesake. All 595 on PubMed
- Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.N Engl J Med · 20132,837 citationsRCR 78.7
- 1,547 citationsRCR 41.6
- Ceritinib in ALK-rearranged non-small-cell lung cancer.N Engl J Med · 20141,179 citationsRCR 32.9
- 1,074 citationsRCR 29.0
- 815 citationsRCR 33.3
- Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest.N Engl J Med · 2021793 citationsRCR 57.3
- Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.N Engl J Med · 1982727 citationsRCR 31.1
- 678 citationsRCR 30.5
- Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.JAMA Dermatol · 2016538 citationsRCR 17.7
- 510 citationsRCR 13.9